Delivery Order SPE2DB20D3101-SPE2DB24FRED3

Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 18, 2024. The $20,757.04 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,526.51 firm-fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S. The firm-fixed-price Delivery Order, valued at $1,138.43, has a completion date of May 9, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Icosapent Ethyl 1 gram capsules. The firm-fixed-price delivery order, valued at $10,219.22, has an ultimate completion date of March 1, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,529.08 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 120 count capsules of Icosapent Ethyl 1 gram, a prescription medication. The award has a completion date of December 6, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,370.64 delivery order is for the supply of icosapent ethyl 1 gram capsules, a cardiovascular medication. This award is under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.70 delivery order covers the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, with a completion date of February 22, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,115.61 firm fixed price delivery order is for the supply of 120-count bottles of the pharmaceutical product Icosapent Ethyl 1 gram capsules. The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corporation with DLA,...
This federal contract award, valued at $3,642.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD), to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product, to support military and veteran healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRED3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Icosapent Ethyl 1 gram capsules. The contract, with a ceiling value of $1,179.60, is a delivery order that runs through March 18, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract supports the procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, medical devices, and other healthcare-related items, to meet the needs of the Department of Defense and other federal agencies.

Generated 2/27/25, 1:36 PM